•
The TPG-National Payor Roundtable (TPG-NPRT) focuses on market access programs within the United States. •
The JeSTARx Group provides evidence-based research and support to the Healthcare Industry. •
The TPG-NPRT maintains a proprietary database of Chief Medical Officers, Chief Pharmacy Officers and other key decision makers from health plans in the United States. •
To control the growth of healthcare costs and ensure appropriate utilization of pharmaceutical products, payors use a variety of management tools, including prior authorization, generic substitution, step therapy, adherence management, and innovative pharmacy benefit designs. Figure 1 ), and the most common degree was MD (55.6%).
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• As the population ages and healthcare costs continue to grow, payors will change the ways they manage their formularies. • The environment for P&T Committee decision making in managed care is undergoing a series of changes. • Payor medical directors and pharmacy directors, who commonly serve as P&T Committee members, have a distinct understanding and opinions as to how to alter the process to adapt to these influences.
Conclusions
Disclosures: None
• Most advisors were happy with their pharmacy benefit design, the most requested changes were more restrictive management programs; followed by changes in tiers/copays. •
The most common desired P&T process change was no change; followed by more frequent meetings/time; and the use of Comparative Effectiveness Research. • Most were happy with their plan's medical benefit management, desired changes included: -Coordination/Integration: Increase involvement with pharmacy department in case management and clinical program development; more pharmacy and medical integration with sales; Better coordination between medical and pharmacy benefits; Combine with pharmacy; integrate pharmacy and medical claims with clinical and laboratory data; pharmacy has all medications under umbrella; cost tied to outcomes; -Coding and analytics: get more resources to work on proper coding; better use of our in-house analytics; more data upon which to make decisions; better data; more EMR alerts; -Management programs: Better use of automated medical management programs; Efficient utilization management program; add local onsite nurse case managers; tighter management with collaboration with providers; -Plan design: Increase patient cost of care; Increased out of pocket maximum; formulary tiers; Move to a defined benefit; -Network: closed network; higher quality network; Mandatory use of in-plan providers before referral out of state; convince network doctors to embrace cost-effective medical practices; risk share contracts; -Time: More time to make decisions; more time; -Education: enhanced staff education; Convince specialty pharmacies to provide drug delivery, purchasing, tracking for medical benefit drugs; increase staff knowledge of interesting guidelines; -Prior authorizations: Prior authorizations of medical benefit drugs; rational prior authorizations; -None: (6). 
